MENU
+Compare
AVBP
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$19.53
Change
+$0.91 (+4.89%)
Capitalization
792.31M

AVBP ArriVent BioPharma Forecast, Technical & Fundamental Analysis

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AVBP with price predictions
Aug 15, 2025

AVBP in -6.20% downward trend, falling for three consecutive days on August 11, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where AVBP declined for three days, in of 79 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

AVBP moved below its 50-day moving average on July 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for AVBP entered a downward trend on August 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AVBP's RSI Oscillator exited the oversold zone, of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 15, 2025. You may want to consider a long position or call options on AVBP as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AVBP just turned positive on August 15, 2025. Looking at past instances where AVBP's MACD turned positive, the stock continued to rise in of 11 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVBP advanced for three days, in of 84 cases, the price rose further within the following month. The odds of a continued upward trend are .

AVBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.171) is normal, around the industry mean (19.407). P/E Ratio (0.000) is within average values for comparable stocks, (50.758). AVBP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.852). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (299.803).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AVBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AVBP is expected to report earnings to fall 12.22% to -79 cents per share on November 13

ArriVent BioPharma AVBP Stock Earnings Reports
Q3'25
Est.
$-0.79
Q2'25
Missed
by $0.14
Q1'25
Missed
by $1.17
Q4'24
Missed
by $0.14
Q3'24
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of -89 cents, missing the estimate of -75 cents. With 274.80K shares outstanding, the current market capitalization sits at 792.31M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
40
Web
https://arrivent.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAZLX82.120.06
+0.07%
Oakmark Select R6
WSMVX27.16N/A
N/A
Wilshire Small Company Value Instl
MUIFX33.67-0.04
-0.12%
Nationwide Institutional Service
TSVIX28.74-0.14
-0.48%
Transamerica Small/Mid Cap Value I
GINNX63.43-0.66
-1.03%
Guinness Atkinson™ Global Inntrs Instl

AVBP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with SYRE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
+4.89%
SYRE - AVBP
47%
Loosely correlated
+0.53%
CRNX - AVBP
44%
Loosely correlated
+3.47%
KYMR - AVBP
43%
Loosely correlated
+2.60%
IPSC - AVBP
42%
Loosely correlated
+2.15%
ATXS - AVBP
42%
Loosely correlated
+1.33%
More